NCODA Awards First International Medically Integrated Pharmacy Center of Excellence Accreditation

Cazenovia, New York – August 20, 2025 – NCODA, Inc., an internationally recognized organization dedicated to promoting enhanced integrated patient care and quality services, proudly announces that Larivière et Massicotte, Pharmaciennes, Inc., a clinical pharmacy based in Quebec, Canada, has been officially awarded the NCODA Center of Excellence (CoE) Multi-Specialty with Oncology Focus Medically Integrated Pharmacy (MIP) Accreditation via the Canadian Pharmacy Accreditation Services, an NCODA company.

This recognition establishes Larivière et Massicotte as the first international pharmacy to receive NCODA CoE Accreditation, reflecting its commitment to delivering the highest standards of quality, safety, and patient-centered care.

“We are thrilled to award Larivière et Massicotte, Pharmaciennes, Inc. with NCODA’s Center of Excellence Medically Integrated Pharmacy Accreditation,” said Kara Sammons, Senior Manager of Accreditation & Member Insights at NCODA. “Their achievement exemplifies a steadfast commitment to innovation, excellence, patient safety.”

NCODA accreditation is a prestigious designation that signifies adherence to rigorous standards in clinical care, pharmacy operations, patient safety, and medication adherence. Through this accreditation, Larivière et Massicotte has demonstrated their ability to provide consistent, high-quality care, while enhancing collaboration across multidisciplinary care teams.

“Achieving this designation validates the work that Larivière et Massicotte is doing in advancing patient care,” said Michael Reff, RPh, MBA, NCODA Executive Director and Founder. “With this being the first NCODA accreditation in Canada, we look forward to collaborating with additional pharmacies committed to our shared mission of ensuring that patients everywhere receive the highest level of care through a model rooted in quality, compassion, and teamwork.”

“Our team is proud to be recognized by NCODA as a Center of Excellence,” said Christine Larivière, pharmacist and co-owner of Larivière et Massicotte, Pharmaciennes, Inc. “This accreditation reinforces our mission to continuously elevate oncology and dedicated pharmacy practices and to deepen our collaborative approach with patients’ local pharmacists and healthcare providers.”

For more information about NCODA and its accreditation programs, visit: https://www.ncoda.org/accreditation

About NCODA
NCODA is a leading medically integrated oncology non-profit organization dedicated to empowering cancer care professionals to deliver positive, patient-centered outcomes through leadership, expertise, quality standards, and best practices. NCODA believes that the coordination of care facilitated through a medically integrated approach enhances quality by engaging all stakeholders on the care team, reduces the opportunity for waste and errors, and avoids needless costs to patients. NCODA offers education and resources to oncology professionals and industry partners through the development of quality standards, best practices, and advocacy. Founded in 2015, NCODA has helped over 3,000 medically integrated practices and over 8,000 medical professionals across the world, in delivering better, personalized oncology care. Our team is a group of committed, patient-centered community builders who connect medical providers with the vital information and resources they need to transform the outcomes of those fighting cancer. For more information, visit www.ncoda.org or follow us on LinkedIn

About Canadian Pharmacy Accreditation Services
Canadian Pharmacy Accreditation Services (CPAS), an NCODA company, reflects NCODA’s expanding commitment to advancing patient-centered pharmacy care across the Canadian healthcare landscape. CPAS delivers a rigorous, yet accessible accreditation pathway designed for pharmacies of all sizes. Built on NCODA’s proven medically integrated pharmacy model, CPAS supports Canadian pharmacies in delivering the highest standards of clinical excellence, quality, and safety through a collaborative, patient-first approach.

About Larivière et Massicotte, Pharmaciennes, Inc.
Larivière et Massicotte, Pharmaciennes, Inc (LMP), is an eco-responsible and carbon-neutral expertise pharmacy established in Quebec, providing pharmacy care services in oncology and rare diseases to patient across the province, in collaboration with the patient’s local pharmacy and care team.  The integrated approach is enabled with the electronic health records, namely Dossier Santé Québec. LMP is a team of 15 pharmacists working in an environment that enables follow-up tailored to the needs of patient with cancer, rare diseases or medications requiring close follow-up. In addition, more than twenty pharmacy technicians, two of whom work on complex reimbursement files, helping to facilitate access to treatments. LMP has assisted more than 20,000 patients to date across Quebec through their Montreal and Quebec City points of services.  For more information, visit https://www.lmpharmaciennes.com/en/  and follow us on LinkedIn or Facebook.

Media Contact:
Katie Edmiston
NCODA
(813) 843-1629